Computer Programs and Systems, Inc., a leading provider of healthcare information solutions, today announced results for the second quarter and six months ended June 30, 2010. Continue Reading
HemaQuest Pharmaceuticals, a clinical stage biotechnology company developing small molecule therapeutics for sickle cell disease, beta thalassemia and EBV-related cancers, announced today the closing of an additional $4M to its Series B financing by new investor, Latterell Venture Partners. This investment brings the total Series B financing to $16M. Continue Reading
HemaQuest Pharmaceuticals, a clinical stage biotechnology company developing small molecule therapeutics for sickle cell disease, beta thalassemia and EBV-related cancers, announced today the closing of an additional $4M to its Series B financing by new investor, Latterell Venture Partners. This investment brings the total Series B financing to $16M. Continue Reading
According to new dental reports by iData Research, the leading global authority in medical device, dental and pharmaceutical market research, the U.S. market for dental implants is expected to regain double-digit growth by 2013, and will help drive the dental prosthetic market to reach over 82 million prosthetic placements by 2016. Continue Reading
According to new dental reports by iData Research, the leading global authority in medical device, dental and pharmaceutical market research, the U.S. market for dental implants is expected to regain double-digit growth by 2013, and will help drive the dental prosthetic market to reach over 82 million prosthetic placements by 2016. Continue Reading
Cannabis Medical Solutions Inc., a leading company specializing in both brick-and-mortar and online merchant payment solutions and financial security products for medical marijuana dispensaries and high-risk merchant accounts, today announced that the Company has signed a Letter of Intent with Green Medicals LLC to acquire equity interest in up to eight (8) medical marijuana dispensaries within the state of Colorado. Continue Reading
Forest Laboratories, Inc. Forest Laboratories Holdings, Ltd., Merz Pharma GmbH & Co. KGaA, and Merz Pharmaceuticals GmbH announced today that they have entered into settlement agreements with all remaining defendants in patent infringement litigation related to Forest’s NAMENDA® (memantine hydrochloride) immediate release tablets. Continue Reading
Draeger Safety Inc. announced today that L. N. Curtis & sons will be a new distributor of Draeger emergency responder equipment in thirteen western states in the United States. Continue Reading
Draeger Safety Inc. announced today that L. N. Curtis & sons will be a new distributor of Draeger emergency responder equipment in thirteen western states in the United States. Continue Reading
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that OSI Electronics, a business within its Optoelectronic and Manufacturing division, has received an order of approximately $4 million for electronic sub-assemblies from an innovative medical device manufacturer. Continue Reading
